Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Pharmacology|May 23, 2022
Monoamine Oxidase Inhibition by Plant-Derived β-Carbolines; Implications for the Psychopharmacology of Tobacco and AyahuascaIlana Berlowitz, Klemens Egger, Paul Cumming
International Review of Neurobiology|June 20, 2025
Molecular brain imaging of psychedelic actionPaul Cumming, Klemens Egger, Gitte M Knudsen
Cellular and Molecular Life Sciences : CMLS|September 10, 2024
Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitorsKlemens Egger, Helena D Aicher, Paul Cumming, et al.
Imaging Neuroscience (Cambridge, Mass.)|October 2, 2025
Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of N,N-dimethyltryptamine and harmine in a meditation retreatKlemens Egger, Daniel Meling, Firuze Polat, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 10, 2025
Population pharmacokinetic-pharmacodynamic modeling of co-administered N,N-dimethyltryptamine and harmine in healthy subjectsAngela Äbelö, John W Smallridge, Robin von Rotz, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 1, 2026
EXPRESS: Global Increases in Brain Glucose Metabolism Following Acute N,N-Dimethyltryptamine and Harmine Administration in Healthy Volunteers: A randomised [18F]FDG-PET StudyKlemens Egger, Robert Bozsak, Helena Dorothea Dorothea Aicher, et al.
Frontiers in Pharmacology|October 16, 2023
A pilot study of cerebral metabolism and serotonin 5-HT2A receptor occupancy in rats treated with the psychedelic tryptamine DMT in conjunction with the MAO inhibitor harmineKlemens Egger, Frederik Gudmundsen, Naja Støckel Jessen, et al.
Journal of Psychopharmacology (Oxford, England)|September 28, 2024
Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreatDaniel Meling, Klemens Egger, Helena D Aicher, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 9, 2025
Examining the pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and harmine in healthy volunteers: Α factorial dose-escalation studyKlemens Egger, Javier Jareño Redondo, Jovin Müller, et al.
Pageof 1